vs

Side-by-side financial comparison of FLANIGANS ENTERPRISES INC (BDL) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $52.6M, roughly 1.6× FLANIGANS ENTERPRISES INC). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 1.5%, a 21.3% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 4.6%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $4.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 4.6%).

Flanigans Enterprises Inc. is a U.S.-based hospitality company focused on the Florida market. It operates a chain of casual dining restaurants under the Flanigan's Seafood Bar and Grill brand, plus retail package liquor stores. Its key customer segments include local residents and regional tourists, offering affordably priced seafood, American comfort food and assorted beverages.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

BDL vs FDMT — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.6× larger
FDMT
$85.1M
$52.6M
BDL
Growing faster (revenue YoY)
FDMT
FDMT
+8508895.4% gap
FDMT
8508900.0%
4.6%
BDL
Higher net margin
FDMT
FDMT
21.3% more per $
FDMT
22.8%
1.5%
BDL
More free cash flow
FDMT
FDMT
$24.0M more FCF
FDMT
$28.5M
$4.5M
BDL
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
4.6%
BDL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BDL
BDL
FDMT
FDMT
Revenue
$52.6M
$85.1M
Net Profit
$805.0K
$19.4M
Gross Margin
Operating Margin
3.2%
17.3%
Net Margin
1.5%
22.8%
Revenue YoY
4.6%
8508900.0%
Net Profit YoY
1363.6%
139.1%
EPS (diluted)
$0.43
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDL
BDL
FDMT
FDMT
Q4 25
$52.6M
$85.1M
Q3 25
$50.0M
$90.0K
Q2 25
$51.9M
$15.0K
Q1 25
$53.4M
$14.0K
Q4 24
$50.0M
$1.0K
Q3 24
$45.4M
$3.0K
Q2 24
$48.8M
$5.0K
Q1 24
$48.1M
$28.0K
Net Profit
BDL
BDL
FDMT
FDMT
Q4 25
$805.0K
$19.4M
Q3 25
$896.0K
$-56.9M
Q2 25
$1.4M
$-54.7M
Q1 25
$2.7M
$-48.0M
Q4 24
$55.0K
Q3 24
$184.0K
$-43.8M
Q2 24
$1.1M
$-35.0M
Q1 24
$1.9M
$-32.4M
Operating Margin
BDL
BDL
FDMT
FDMT
Q4 25
3.2%
17.3%
Q3 25
3.3%
-67983.3%
Q2 25
5.5%
-396373.3%
Q1 25
6.6%
-383007.1%
Q4 24
1.5%
Q3 24
0.7%
-1704400.0%
Q2 24
4.4%
-849120.0%
Q1 24
5.6%
-136200.0%
Net Margin
BDL
BDL
FDMT
FDMT
Q4 25
1.5%
22.8%
Q3 25
1.8%
-63195.6%
Q2 25
2.7%
-364386.7%
Q1 25
5.0%
-342657.1%
Q4 24
0.1%
Q3 24
0.4%
-1461433.3%
Q2 24
2.3%
-699060.0%
Q1 24
4.0%
-115717.9%
EPS (diluted)
BDL
BDL
FDMT
FDMT
Q4 25
$0.43
$0.43
Q3 25
$0.48
$-1.01
Q2 25
$0.75
$-0.98
Q1 25
$1.45
$-0.86
Q4 24
$0.03
Q3 24
$0.11
$-0.79
Q2 24
$0.60
$-0.63
Q1 24
$1.04
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDL
BDL
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$402.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$66.0M
$505.7M
Total Assets
$142.1M
$566.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDL
BDL
FDMT
FDMT
Q4 25
$402.7M
Q3 25
$305.1M
Q2 25
$732.0K
$293.2M
Q1 25
$244.0K
$321.4M
Q4 24
$424.9M
Q3 24
$501.9M
Q2 24
$541.9M
Q1 24
$525.9M
Total Debt
BDL
BDL
FDMT
FDMT
Q4 25
Q3 25
$20.9M
Q2 25
Q1 25
Q4 24
Q3 24
$22.2M
Q2 24
Q1 24
Stockholders' Equity
BDL
BDL
FDMT
FDMT
Q4 25
$66.0M
$505.7M
Q3 25
$65.2M
$369.0M
Q2 25
$64.3M
$420.9M
Q1 25
$64.0M
$469.7M
Q4 24
$61.6M
$510.6M
Q3 24
$61.2M
$552.9M
Q2 24
$61.3M
$588.3M
Q1 24
$61.1M
$600.6M
Total Assets
BDL
BDL
FDMT
FDMT
Q4 25
$142.1M
$566.7M
Q3 25
$140.6M
$424.0M
Q2 25
$140.7M
$473.6M
Q1 25
$143.3M
$515.7M
Q4 24
$146.9M
$560.4M
Q3 24
$142.1M
$604.0M
Q2 24
$143.1M
$620.1M
Q1 24
$144.4M
$629.9M
Debt / Equity
BDL
BDL
FDMT
FDMT
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
Q4 24
Q3 24
0.36×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDL
BDL
FDMT
FDMT
Operating Cash FlowLast quarter
$4.9M
$28.6M
Free Cash FlowOCF − Capex
$4.5M
$28.5M
FCF MarginFCF / Revenue
8.5%
33.5%
Capex IntensityCapex / Revenue
0.9%
0.1%
Cash ConversionOCF / Net Profit
6.14×
1.47×
TTM Free Cash FlowTrailing 4 quarters
$2.2M
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDL
BDL
FDMT
FDMT
Q4 25
$4.9M
$28.6M
Q3 25
$3.4M
$-46.5M
Q2 25
$1.4M
$-43.4M
Q1 25
$-2.0M
$-47.8M
Q4 24
$7.7M
$-134.6M
Q3 24
$-29.4M
Q2 24
$3.1M
$-30.2M
Q1 24
$-29.1M
Free Cash Flow
BDL
BDL
FDMT
FDMT
Q4 25
$4.5M
$28.5M
Q3 25
$2.4M
$-46.6M
Q2 25
$-1.8M
$-43.4M
Q1 25
$-3.0M
$-48.4M
Q4 24
$7.0M
$-138.4M
Q3 24
$-31.2M
Q2 24
$2.2M
$-30.6M
Q1 24
$-29.8M
FCF Margin
BDL
BDL
FDMT
FDMT
Q4 25
8.5%
33.5%
Q3 25
4.9%
-51765.6%
Q2 25
-3.4%
-289620.0%
Q1 25
-5.5%
-345635.7%
Q4 24
13.9%
-13837100.0%
Q3 24
-1038966.7%
Q2 24
4.5%
-611840.0%
Q1 24
-106421.4%
Capex Intensity
BDL
BDL
FDMT
FDMT
Q4 25
0.9%
0.1%
Q3 25
1.9%
101.1%
Q2 25
6.1%
440.0%
Q1 25
1.8%
4507.1%
Q4 24
1.5%
378600.0%
Q3 24
59266.7%
Q2 24
1.8%
6980.0%
Q1 24
2535.7%
Cash Conversion
BDL
BDL
FDMT
FDMT
Q4 25
6.14×
1.47×
Q3 25
3.75×
Q2 25
1.02×
Q1 25
-0.73×
Q4 24
140.02×
Q3 24
Q2 24
2.75×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDL
BDL

Restaurant Food Sales$30.9M59%
Package Store Sales$13.3M25%
Restaurant Bar Sales$7.9M15%

FDMT
FDMT

Segment breakdown not available.

Related Comparisons